Your cart is currently empty!

Atomfair 1H-Pyrrolo(1,2-a)imidazole, 1-benzyl-6-phenyl- C19H16N2
Description 1-Benzyl-6-phenylpyrrolo[1,2-a]imidazole (CAS No. 54977-92-3) is a high-purity heterocyclic organic compound with the molecular formula C19H16N2. This structurally unique fused-ring system features a pyrroloimidazole core substituted with benzyl and phenyl groups, offering versatile reactivity for synthetic and medicinal chemistry applications. The compound is supplied as a stable solid with ??95% purity (HPLC) and is characterized by 1H NMR, 13C NMR, and mass spectrometry. Ideal for pharmaceutical research, this building block enables the development of novel bioactive molecules due to its privileged scaffold. Proper storage at 2-8??C under inert atmosphere is recommended for long-term stability.
Description
Description
1-Benzyl-6-phenylpyrrolo[1,2-a]imidazole (CAS No. 54977-92-3) is a high-purity heterocyclic organic compound with the molecular formula C19H16N2. This structurally unique fused-ring system features a pyrroloimidazole core substituted with benzyl and phenyl groups, offering versatile reactivity for synthetic and medicinal chemistry applications. The compound is supplied as a stable solid with ??95% purity (HPLC) and is characterized by 1H NMR, 13C NMR, and mass spectrometry. Ideal for pharmaceutical research, this building block enables the development of novel bioactive molecules due to its privileged scaffold. Proper storage at 2-8??C under inert atmosphere is recommended for long-term stability.
- CAS No: 54977-92-3
- Molecular Formula: C19H16N2
- Molecular Weight: 272.3
- Exact Mass: 272.131348519
- Monoisotopic Mass: 272.131348519
- IUPAC Name: 1-benzyl-6-phenylpyrrolo[1,2-a]imidazole
- SMILES: C1=CC=C(C=C1)CN2C=CN3C2=CC(=C3)C4=CC=CC=C4
- Synonyms: 37959-40-3, 1-benzyl-6-phenyl-1h-pyrrolo[1,2-a]imidazole, 1-Benzyl-6-phenyl-1H-pyrrolo(1,2-a)imidazole, BRN 0886494, 1H-Pyrrolo(1,2-a)imidazole, 1-benzyl-6-phenyl-
Application
This compound serves as a valuable intermediate in medicinal chemistry for developing kinase inhibitors and GPCR modulators. The fused heterocyclic structure makes it particularly useful for constructing pharmacophores in drug discovery programs. Researchers utilize it to explore structure-activity relationships in anticancer and anti-inflammatory agent development.
If you are interested or have any questions, please contact us at support@atomfair.com